Clinical TrialID 5332
Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms
NCT01381120
Flank Pain|Urinary Bladder, Overactive
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 5332
- Evidence Id
- 5332
- Core Evidence Id
- 5332
- Source Clinical Trial Id
- 5318
- Herb2 Clinical Trial Id
- HBCT005318
- Nct Id
- NCT01381120
- Title
- Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms
- Status
- Completed
- Phase
- Phase 4
- Study Result
- Yes
- Study Condition
- Flank Pain|Urinary Bladder, Overactive
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DRUG: Solifenacin succinate treatment|DRUG: Oxycodone and acetaminophen combination treatment
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Child, Adult, Older_Adult
- Enrollment
- 84
- Outcome Measure
- Change in Post-ureteroscopy Stent-induced Pain, Measured through the use of the ureteral stent symptom questionnaire. Patients reported pain on a scale of 0 to 10 (0 being the absence of pain and 10 being the most excruciating pain of their life). The questionnaire was administered a couple days post-op and once again several weeks later. The mean difference (baseline minus 3 months) on this continuous scale was used for this outcome measure., Baseline and 3 months.
- Sponsor Collaborator
- Barrie Urology Associates|Astellas Pharma Canada, Inc.
- Funded By
- OTHER
- Location
- Barrie Urology Associates - The Male/Female Health and Research Centre, Barrie, Ontario, L4M 7G1, Canada
- Other Id
- ARC-2010-03
- Start Date
- 2010-10
- Primary Completion Date
- 2012-06
- Completion Date
- 2012-06
- First Posted
- 2011-06-27
- Results First Posted
- 2012-08-22
- Last Update Posted
- 2012-08-30
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT01381120
- Title Cn
- Title En
- Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms
- Bilingual Status
- semi_complete